Overexpressed Rad51 (Harris et al., 2018), BRCA1 (Zhu et al., 2018), and MDC1 (Singh et al., 2020) contribute to genomic integrity and chemoresistance in cancer. This evidence concerns the gene BRCA1 and cancer.